CMV/AAT Promoter of MAR-based Episomal Vector Enhanced Transgene Expression in Human Hepatic Cells

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2023 Oct 9

PMID 37810190

Authors

Jihong Zhang

Tian-Yun Wang

Chunbo Zhang

Chunliu Mi

Shaolei Geng

Yuanyuan Tang

Xiaoyin Wang

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-023-03774-x.

References

Haase R, Magnusson T, Su B, Kopp F, Wagner E, Lipps H . Generation of a tumor- and tissue-specific episomal non-viral vector system. BMC Biotechnol. 2013; 13:49. PMC: 3728224. DOI: 10.1186/1472-6750-13-49. View

Kamiya H, Goto H, Harashima H . Effects of non-B DNA sequences on transgene expression. J Biosci Bioeng. 2009; 108(1):20-3. DOI: 10.1016/j.jbiosc.2009.02.013. View

Maestro S, Weber N, Zabaleta N, Aldabe R, Gonzalez-Aseguinolaza G . Novel vectors and approaches for gene therapy in liver diseases. JHEP Rep. 2021; 3(4):100300. PMC: 8203845. DOI: 10.1016/j.jhepr.2021.100300. View

Shyamala N, Kongettira C, Puranam K, Kupsal K, Kummari R, Padala C . In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size. Sci Rep. 2022; 12(1):3574. PMC: 8897451. DOI: 10.1038/s41598-022-05198-8. View

Fornes O, Castro-Mondragon J, Khan A, van der Lee R, Zhang X, Richmond P . JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2019; 48(D1):D87-D92. PMC: 7145627. DOI: 10.1093/nar/gkz1001. View

Argyros O, Wong S, Niceta M, Waddington S, Howe S, Coutelle C . Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector. Gene Ther. 2008; 15(24):1593-605. DOI: 10.1038/gt.2008.113. View

Kamiya H, Fukunaga S, Ohyama T, Harashima H . The location of the left-handedly curved DNA sequence affects exogenous DNA expression in vivo. Arch Biochem Biophys. 2007; 461(1):7-12. DOI: 10.1016/j.abb.2007.02.012. View

Ding B, Li T, Zhang J, Zhao L, Zhai G . Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems. Curr Gene Ther. 2012; 12(2):92-102. DOI: 10.2174/156652312800099625. View

Tossolini I, Gugliotta A, Lopez Diaz F, Kratje R, Prieto C . Screening of CHO-K1 endogenous promoters for expressing recombinant proteins in mammalian cell cultures. Plasmid. 2022; 119-120:102620. DOI: 10.1016/j.plasmid.2022.102620. View

10.

Zhang J, Zhang J, Cheng S, Yang W, Li S . Enhanced transgene expression using two β-globin MARs flanking expression cassettes in stably transfected CHO-K1 cells. 3 Biotech. 2019; 9(11):435. PMC: 6825625. DOI: 10.1007/s13205-019-1971-6. View

11.

Grabe N . AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol. 2002; 2(1):S1-15. View

12.

Castro-Mondragon J, Riudavets-Puig R, Rauluseviciute I, Lemma R, Turchi L, Blanc-Mathieu R . JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2021; 50(D1):D165-D173. PMC: 8728201. DOI: 10.1093/nar/gkab1113. View

13.

Wang T, Zhang J, Jing C, Yang X, Lin J . Positional effects of the matrix attachment region on transgene expression in stably transfected CHO cells. Cell Biol Int. 2009; 34(2):141-5. DOI: 10.1042/CBI20090017. View

14.

Mulia G, Picanco-Castro V, Stavrou E, Athanassiadou A, Figueiredo M . Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy. Hum Gene Ther. 2021; 32(19-20):1076-1095. PMC: 8819515. DOI: 10.1089/hum.2020.310. View

15.

Cabrera-Perez R, Vila-Julia F, Hirano M, Mingozzi F, Torres-Torronteras J, Marti R . Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum Gene Ther. 2019; 30(8):985-998. PMC: 7647930. DOI: 10.1089/hum.2018.217. View

16.

Miao C, Thompson A, Loeb K, Ye X . Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol Ther. 2001; 3(6):947-57. DOI: 10.1006/mthe.2001.0333. View

17.

Argyros O, Wong S, Fedonidis C, Tolmachov O, Waddington S, Howe S . Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver. J Mol Med (Berl). 2011; 89(5):515-29. DOI: 10.1007/s00109-010-0713-3. View

18.

De Simone V, Cortese R . A negative regulatory element in the promoter of the human alpha 1-antitrypsin gene. Nucleic Acids Res. 1989; 17(22):9407-15. PMC: 335141. DOI: 10.1093/nar/17.22.9407. View

19.

Jia Y, Guo X, Ni T, Lu J, Wang X, Wang T . Novel short synthetic matrix attachment region for enhancing transgenic expression in recombinant Chinese hamster ovary cells. J Cell Biochem. 2019; 120(10):18478-18486. DOI: 10.1002/jcb.29165. View

20.

Inukai S, Kock K, Bulyk M . Transcription factor-DNA binding: beyond binding site motifs. Curr Opin Genet Dev. 2017; 43:110-119. PMC: 5447501. DOI: 10.1016/j.gde.2017.02.007. View